SlideShare a Scribd company logo
Best  Practices  for  a  Data-­driven
Approach  to  Test  Utilization
MICHAEL  ASTION,  MD,  PHD
AUG.  30,  2016
Michael  Astion,  MD,  PhD
• Medical  Director,  Department  of  Laboratories,
Seattle  Children’s  Hospital
• Clinical  Professor,  University  of  Washington,
Department  of  Laboratory  Medicine
Financial  disclosure  statement:
• Univ.  Washington  Intellectual  Property  licensed  to
– EviCore  Inc.,  (Guide  to  Lab  Utilization)
– Medical  Training  Solutions
• Dr.  Astion  is  employed  by  Seattle  Children’s  Hospital  and  is  here  representing  Seattle  Children’s.
Agenda
• Utilization  Management  (UM)
– Background
• Value  in  lab  testing.  Why  is  genetics  different?
• Why  improve  utilization?
• Trends  in  healthcare  affecting  UM
– Data  from  insurance  claims
– Interventions  to  improve  test  ordering
• Seattle  Children’s  UM  plan/Pediatric  Laboratory  Utilization  Guidance  
Service  (PLUGS)
• Conclusions
Why  improve  lab  utilization?
• ¯ patient  costs
• ¯ direct  lab  costs
• ¯ societal  costs
• ¯ false  +  results  
especially  with  ¯ pretest  probability
• ¯ worry
• ¯ false  Dx,  associated  harms
• ¯ unnecessary  work
Value  =  Quality/Cost
Warren JS. Lab test utilization program… Am J Clin Path. 2013;139:289-297.; Lewandrowski K. Managing utilization of new diagnostic tests. Clin Leadersh Manag Rev.
2003 Nov-Dec;17(6):318-24.; Kim  JY  et  al.  Utilization  management  in  a  large  urban  academic  medical  center.  AJCP.  2011;;135:108-­118.
Root  causes  of  lab  overutilization    
Care  providers
Patients  Labs
­ testing
Health  system
google  …$$  incentive…
fee  for  service malpractice  fear..  
gene  patents...
$  incentive…
dissatisfaction…
more  is  better...
mktg  pressure…
coding  system...
patient  pressure…
wellness  movement…
Univ  Washington-­ EviCore  collaboration  to  study  lab  utilization  in  
commercially-­insured  populations  in  the  USA  (2008  – present)  
• Study  of  national,  regional  lab  insurance  claims  databases
• Characteristics  of  largest  insurance  dbase  we  have  studied:
– 1  year  of  data  (2009)
– 3.5  million  covered  individuals  (members)
– 8.2  million  doctor’s  visits  in  48  states
– Total  spent  on  lab  was  $668  million.    
– Lots  of  overutilization.
• Example:  2.3%  of  members  had  ANA  test  (about  $  1  million  spent).  Prevalence  of  
Lupus  in  population  is  0.2  – 1.5  per  1000
Eckert  LO,    Tait  JF,  Astion  ML,  et  al    2010.  Use  of  Molecular  Diagnostics  for  Lower  Genital  Tract  Complaints:    Comparison  of  Practice  Patterns  with  Published  Guidelines.  Am  
College  of  Obstetrics  and  Gynecology  Annual  Meeting.;; Eckert  LO,  Astion  ML,  Tait  JF,    et  al.  2011.Use  of  molecular  diagnostics  in  women  without  genital  symptoms  presenting  for  
Pap  smear:  How  common?  How  costly?  Infectious  Disease  Society  for  Obstetrics  and  Gynecology  (winner  of  outstanding  poster  award).;;  Bradley  SM,  Tait  J,  O’Brien  KD  et  al.  
2011.  Use  of  novel  cardiovascular  risk  biomarkers  in  clinical  practice.  Annual  Meeting  for  Quality  of  Care  and  Outcomes  Research  in  Cardiovascular  Disease  and  Stroke.  
Major  domains  of  overutilization
Bundling  and  nonstandard  tests  are  drivers  in  all  domains
• Wellness
• CVD  risk
• Pain
• Women’s  health  (cervicitis,  vaginitis)
• Nutrition  and  metals
• Flow  cytometry
• Allergy
• Autoantibodies  (e.g.,  celiac  test  bundles)
• Inpatients:  daily  labs
• Genetic  testing,  especially  by  non-­geneticists
Adults
Peds
Eckert  LO,    Tait  JF,  Astion  ML,  et  al    2010.    Am  College  of  Obstetrics  and  Gynecology  Annual  Meeting.;; Eckert  LO,  Astion  ML,  Tait  JF et  al.  2011.  Infectious  Disease  Society  for  
Obstetrics  and  Gynecology;; Bradley  SM,  Tait  J,  O’Brien  KD,    et  al.  2011.  Annual  Mtg,  Quality  of  Care  and  Outcomes  Research  in  Cardiovascular  Disease  and  Stroke.  
Overuse/  Misuse  of  Allergen-­specific  tests  
Novel  biomarkers  are  overused  (4.4%  waste  of  $)
Allergen specific  test #  visits  
(Dates of  Service)
$  spent  (%  of  total)
IgE allergy  test 18553 $2,315,447  (95.7%)
IgG-­IgG4 allergy  test 28 $71,420          (3.0%)
ALC  antibody 48 $33,267            (1.4%)
• Astion  M,  Tait  J,    et  al.  CareCore  collaboration,  unpublished  data
• Used  our  largest  annual  database  of  3.5  million  covered  individuals
• >500  clinical  labs  represented  in  the  >18,000  dates  of  service
For  allergen-­specific  IgE  testing,  28  tests  per  doctor’s  visit  is  the  norm!
26  %
19  %
24  %
23  %
7  %
0
1000
2000
3000
4000
5000
6000
1  -­ 10  u 11  -­ 20  u 21  -­30  u   31  -­ 40  u >  40  u
DOS
Range  of  IgE  units
• N  =  18,553  doctor’s  visits
• Ave  units  of  allergen  specific  IgE  :  28 (SD:13,  Range:  12  – 71)
• 54%  of  workups  are  associated  with  testing  >  21  allergens
INTERVENTIONS  to  improve  utilization  require  
backbone,  energy,  and  data
“I’m  revitalized  and  ready  to  
decrease  Vitamin  D  testing!”
Seattle  Children’s  Hospital  approach  to  utilization  
management  (UM)  is  typical  and  illustrative
• Utilization  management  committee,  meets  weekly
– 3  genetic  counselors
– 4  -­ 6  doctoral  level  staff  including  pathologists,  medical  geneticists,  and  clinical  
chemists
– 2  lab  managers
– Subcommittees  for  special  topics  (e.g.  exome  testing)
• 1  GC,    1  doctor  on  call  for  UM  each  week.
• All  UM  cases  recorded  in  database.  Dbase  allows  case  tracking,  
consistency  in  case  resolution,  and  enables  research  and  QI
• Emphasis  is  on  sendout  tests,  but  all  aspects  of  UM  are  covered.
Dickerson  JA,  Cole  B,  Conta  JH,    et  al..  Improving  the  value  of  costly  genetic  reference  laboratory  testing  with  active  utilization  management.  Arch  Path  Lab  Med.  2014  
Jan;;138(1):110-­3.
Seattle  Children’s  Hospital:  What  test  requests  are  
placed  under  active  management  with  review?  
– Tests  >  $700
– Tests  ordered  for  multiple  genes
– Requests  to  use  alternate  labs
– Requests  for  banned  tests  or  labs
– Request  for  test  labeled  in  lab  system  as  “Under  Management”    (e.g.,  
reverse  T3)
Dickerson  J,  et  al.    Ten  Ways  to  Improve  the  Quality  of  Send-­out  Testing.  Clin  Lab  News.  2012;;38(4):  12-­13.  www.aacc.org/publications/cln/2012/april/Pages/SendOutTesting.aspx#;;  
Dickerson  JA,  Cole  B,  Conta  JH,    et  al..  Improving  the  value  of  costly  genetic  reference  laboratory  testing  with  active  utilization  management.  Arch  Path  Lab  Med.  2014  
Jan;;138(1):110-­3.  
Where  should  health  systems  focus  interventions?  
It  is  most  realistic  to  focus  on  care  providers.
Perverse
Financial
Incentives
MD, RN,
PA, other
Patient
Pressure
Marketing
Pressure Lab
Test result
Test order
Astion  M.  Quackery  interventions:  The  hopelessness  and  the  hope.  Laboratory  Errors  and  Patient  Safety.2007.  4(1):  1  – 6.
Common  weaker  interventions  to  improve  lab  utilization
• Memos
• Call  for  enhanced  vigilance
• Training
– Distribution  of  materials
– Formal  continuing  education
MEMO  10/07/10
To:  All  Providers  in  Clinic  X
From:  Dr.  BigEgo,  Clinic  Chief
Re:  Lab  test  utilization
Stop  ordering  the  wrong  tests,  
and  start  ordering  the  right  tests.  
Please,  don’t  order  too  many  
tests.    Be  more  careful.  You  all  
don’t  know  what  you  are  doing.  
• Posting  of  guidelines  
on  the  requisition
• Computerized  
reminders  regarding  
utilization  guidelines
Utilization  Management  – Overview  of  Interventions
Ÿ Utilization  report  cards  with  
peer  review
Ÿ Changes  to  manual  
requisition
Ÿ CPOE  templates
Ÿ LIS  flagging  of  duplicate  
orders
Ÿ EMR  hard  and  soft  stops.
Ÿ Privileging
Ÿ Sendouts  formulary
Ÿ Forbidding  tests
Ÿ Requirement  for  higher  
level  collaboration  or  
approval  (e.g.  
Pathologist  or  genetic  
counselor  consultation)
Gentle Strong
Strength of Guidance
Solomon DH et al. Techniques to improve…use of diagnostic tests. JAMA. 1998; 280:2020-2027.; Warren JS. Laboratory test utilization program: structure and impact in a large
academic medical center. Am J Clin Pathol. 2013;139:289-297.
Medium
Influencing  physician  behavior
IT  intervention Physician
happiness
Hard  stops
Soft  stop
Change  to  CPOE  templates,  
Test  Definitions  and  Names
Report  Cards  -­plain
Report  Cards  with  +++  
reinforcement
One  useful  tactic  under  this  approach  is  
nudging,  i.e.  steering  physicians  in  the  
direction  that  we  know  is  usually  right,  
while  still  giving  them  freedom  to  deviate  
where  appropriate.  This  requires  
engineering  the  information  environment  in  
which  they  act,  such  that  usually  correct  
actions  become  the  default,  and  deviation  
requires  a  conscious  choice.
—Dr.  Brian  Jackson,  ARUP/Univ  Utah
Jackson  BR.  Nudging  our  way  to  more  efficient  care.  Clinical  Laboratory  News.  April  
1,  2016.  www.aacc.org/publications/cln/articles/2016/april/nudging-­our-­way-­to-­more-­
efficient-­care-­how-­to-­win-­friends-­among-­doctors-­while-­influencing-­them
Computerized  Reminders:  Less  is  More
“I wouldn’t have ordered that! Do you
know what you are doing? Y / N”
“Would you like to
discontinue standing order
for electrolytes? Y / N”
“Recommended screening
test for thyroid disease is
TSH.”
Niazkhani et al. J Am Med Inform Assoc. 2009 16(4):539-49. Epub 2009 Apr 23.
Changes  to  CPOE,  manual  requisitions,  and  test  
definitions…  
• …should  send  obsolete  tests  into  
the  sunset  after  sending  a  phase  
out  notice.
• …for  manual  requisitions,  need  to  
be  supported  by  a  policy  and  
procedure  to  destroy old  
requisitions
• Make  unwanted  behavior  difficult  
to  achieve;;  make  desired  behavior  
easy
Portion  of  a  requisition  for  genetics  tests  
Effect  of  removing  ionized  Ca+2  from  requisition  and  replacing  it  with  reflexive  
Ca+2  panel,  which  is  a  total  Ca+2,  and  ionized  Ca+2  if  total  Ca+2  <  8.0  mg/dL
0
1000
2000
3000
4000
5000
6000
Month
Monthly  tally:  iCa+2
Hospital  1
Hospital  2
Baird  et  al.  Clin  Chem.  2009  Mar;;55:533-­40.  
EMA  Monthly  Volumes
Intervention  1:  email  with  phase  out  notice;;  other  communication
Intervention  2:  Remove  
from  orders
0  orders  
after  Jan  
2015
Monitor  Impact  of  an  intervention  to  eliminate  Endomysial  Antibody  
(EMA  testing)  in  celiac  disease
Example  of  a  typical  intervention:
1,25  Dihydroxyvitamin  D      
Problem:
• 1,25  Dihydroxyvit  D  is  common  send-­out  with  >  300  tests/yr
• Retrospective  chart  review  found  68%  of    1,25  Vit  D  were  ordered  in  error  and  25  Vit  D  was  
intended.  
Intervention:
• Email  describing  use  of  the  two  Vit  D  tests,  and  asking  if  provider  wants  to  change    to  25  Vit  D.    
• Email  managed  by  front-­line  sendouts  staff.
Dickerson  J,  Cole  B,  Jack  R,  Astion  M.    Another  laboratory  test  utilization  program:  our  approach  to  reducing  unnecessary  1,25  Vitamin  D  orders  with  a  simple  intervention.  
Am  J  Clin  Pathol.  2013.  140(3):446-­7.
1,25  Vitamin  D  Intervention
The  lab  received  a  request  for  1,25  dihydroxy  vitamin  D  on  
your  patient.
In  our  lab,  we  found  that  this  is    ordered  accidentally  68%  of  
the  time.
Utility  of  25-­ Vit  D  vs.  1,25  Vit  D  
Two  options:
1. Cancel  and  add-­on  25-­OH  Vit  D
2. Proceed  with  original  order
Dickerson  J,  Cole  B,  Jack  R,  Astion  M.    Another  laboratory  test  utilization  program:  our  approach  to  reducing  unnecessary  1,25  Vitamin  D  orders  with  a  simple  intervention.  
Am  J  Clin  Pathol.  2013.  140(3):446-­7.
0
5
10
15
20
25
30
35
Number  of  Orders
Cancelled
Approved
Intervention
Privileging  added
Effect  of  an  email  to  doctors  on  Vitamin  1,25  D  orders  
(2012-­2013,  7  months)
After  intervention:    
• 58%  (n=134)  of  the  1,25  
Vit  D    orders  were  
changed  to  25  Vit  D.
• 1,25  Vit  D  now  <10  /mo
Dickerson  J,  Cole  B,  Jack  R,  Astion  M.    Another  laboratory  test  utilization  program:  our  approach  to  reducing  
unnecessary  1,25  Vitamin  D  orders  with  a  simple  intervention.  Am  J  Clin  Pathol.  2013.  140(3):446-­7.
Doctors  Love  the  1,25  Vitamin  D  Intervention
I  am  not  making  these  up.
“Thanks  so  much  for  your  help  (and  education). You  are  exactly  right—please  
cancel  the  order  of  1,25  and  I’ll  add  on  for  25  hydroxy. ”  
“Thank  you  so  much  for  the  email. You  are  correct  I  wanted  25-­hydroxy. I  will  
cancel  and  reorder.”  
Privileging
“Dear  Send-­out  Team,
I’ve  created  a  list  of  our  privileged  providers  who  do  not  need  to  be  
contacted  regarding  ______  orders.  Simply,  send  these  tests  out.  ”
SBAR:  Too  many  CBC-­DIFFs
Situation:      High  proportion  of  CBCs  are  ordered  with  a  differential.
Background: CBC-­Diffs  create  more  manual  work,  and  can  slow  down  
the  laboratory  TAT  during  peak  times.    
Assessment: CBCs  (without  differential)  are  sufficient  in  many  patient  
populations.
Recommendation:    Analyze  the  data,  identify  target  populations/divisions  
to  pilot  interventions.
Phase  1:  Provider  Feedback
Phase  2:  Removed  CBC-­Diff  from  CICU  Ordersets
85%  of  CBCs  include  a  differential Cardiac  ICU  utilization  decreased  by  50%
CBC
CBC-­DIFF
Thanks  to  Patrick  Mathias,  MD  PhD
CICU NICU PICU
Months  (Jan  2015  – June  2016)
100
90
80
70
60
50
40
30
20
10
Proportion  CBC-­DIFF  to  CBC  +  CBC-­DIFF
Genetic  Counselors  as  a  form  of  enhanced  supervision
In  this  study:  1  /  3  of    
genetic  test  orders  
were  in  error  and  
correcting  the  order  
improved  patient  care  
and  saved  $  for  
patients  and  
hospitals.
Miller C.  Clin  Lab  News. 2012:  38(1).  www.aacc.org/publications/cln/2012/january
Email  template  to  physicians  who  are  not Medical  Geneticists  
but  who  are  ordering  expensive  genetic  tests  
Lab  received  expensive,  unusual  request  on  your  patient:
You  have  3  options:
1.  Involve  genetics  or  lab  GC
2.  Hold  for  pre-­authorization  
3.  Proceed  after  telling  $cost  to  patient
Info  on  completing  insurance  pre-­auth
A  day  in  the  UM  life  at  SCH…  32%  of  genetic  test  
requests  are  canceled  or  decreased
Request  
received  by  
SO  team
E-­mail  to  
Lab  GC/
SO  Consultant
Case  review  
&  
Adjudication
Approved
Additional  
information  
needed
Discussion  
with  ordering  
provider
Modified Cancelled
Outcome
68%
10%22%
Dickerson  JA,  Cole  B,  Conta  JH,    et  al..  Improving  the  value  of  costly  genetic  reference  laboratory  testing  with  active  utilization  management.  Arch  Path  Lab  Med.  2014  Jan;;138(1):110-­
3.  
$6,033,371*
Total  genetic  requests  
$980,953
savings  
$5,052,418
Actual
32%  order  
modification
~$340  saved
per  request
*Data  collected  Sept  2011  – Feb  2016
N=2908  genetic  cases
Seattle  Children’s  Hospital
Financial  Implications  of  UM
SCH  UM  Dashboard
Turn-­around  Time
Requests  Over  Time
Cost  – Cost  Savings
Request  Details
PLUGS:  nationalizing  our  experience
Mission/Vision
• Needs  expenses  while  
increasing  the  value  of  
testing  to  patients.
• Be  the  #1  provider  of  
services  that  promote  
pediatric  test  utilization  
management  (UM)  
programs  in  hospitals  and  
health  systems.
Goal
• Help  hospitals  implement  
/  strengthen  their  own  UM  
programs
Outcomes
• Decrease  ordering  errors  
• Decrease  send-­out  bill  for  
genetic  tests  by  20-­40%
• Decrease  send-­out  bill  for  
non-­genetic  tests  by  10%
• Decrease  patient  
complaints  by  reducing  
out  of  pocket  expenses  
and  unnecessary  testing.
Pediatric  Laboratory  Utilization  Guidance  Services
THANK  YOU  TO  OUR  SPONSORS  &  PARTNERS:
56  INSTITUTIONS,  AND  COUNTING…    
Health  Partners:  Regions  Hospital  &  Park  Nicolette  Hospitals  
Intermountain/Primary  Children’s  Hospital
Johns  Hopkins  Hospital  
Lancaster  General  Hospital
Le  Bonheur  Children’s  Hospital  
Lurie  Children’s  Hospital  Chicago
Mercy  Children’s  Hospital  – St.  Louis
Meriter-­ Unity  Point  Health
Medical  Neurogenetics  (MNG)  Laboratories
MultiCare  Tacoma  General  
Nationwide  Children's  Hospital  
Nemours/Alfred  I.  duPont  Hospital  for  Children
Nationwide  Children’s  Hospital
Norton  Healthcare
Oregon  Health  Sciences  University
Phoenix  Children’s  Hospital
PWN  Health
Quest  Diagnostics
Salem  Health
Stanford  Health  Care
St.  Louis  Children’s  Hospital
Tricore  Reference  Lab
University  of  Florida-­ Shands  
University  of  Michigan
University  of  Washington
Wake  Forest  Baptist  Health
York  Hospital  (WellSpan  Health  System)
Akron  Children's  Hospital
Arkansas  Children’s  Hospital
Baylor  Genetics
Bronson  Methodist  Hospital
Blood  Center  of  Wisconsin
Boston  Children’s  Hospital
Cardinal  Glennon,  SSMH
CentraCare  Health
Children’s  of  Alabama  
Children’s  Healthcare  of  Atlanta
Children's  Hospital  &  Clinics  of  MN
Children's  Hospital  of  Colorado  
Children’s  Hospital  of  Los  Angeles
Children’s  Hospital  of  Philadelphia
Children’s  Hospital  of  Pittsburgh  of  UPMC
Children’s  Hospital  of  Wisconsin
Children’s  Mercy  Hospital
Children’s  National  Medical  Center
Cincinnati    Children’s  Hospital
Cleveland  Clinic
Connecticut  Children’s  Hospital
Dayton  Children’s  Hospital    
Dell  Children’s  
Fairview  Health  Services
GeneDx
PLUGS    provides…
UM  Tools
• Needs  assessment  and  1  year  
plan
• Policies,  procedures  &  
communication  templates  that  
help  providers  reduce  
unnecessary  testing  &  correct  
test  orders
• Database  for  collecting,  
tracking  &  analyzing  UM  
cases
• Tools  to  assess  risk  of  errors  
in  send-­outs
• Provider  satisfaction  survey
Communication
• Office  hours/call  center
• Weekly  newsletter
• Member  teleconferences  with  
presentations  by  SCH  team  &  
members
• Website:  
www.seattlechildrens.org
• Discussion  forum
Education
• Tips  &  tricks  from  PLUGS  
experts
• UM  learning  modules
• UM  webinars
• Case  of  the  Week
• Extensive  materials  on  how  to  
get  a  UM  program  started  in  a  
lab  or  hospital
• PLUGS  Summit
PLUGS  Summit  (June  2017)
• 10  hours,  CME/CEU
• Sharing  best  practices
• Debates  /  Roundtables
• Posters
• Networking  (nice  party)
• Largest  lab  utilization  management  
gathering
– >175  participants
– Labs
– IT  companies
– Insurance  companies
Conclusions  and  Thanks!
• Lab  test  utilization  management    
improves  value  to  patients.
• It  is  here  to  stay.
• Over  the  next  10  years,  most  testing  will  
be  actively  managed  by  insurers  and  
hospital  systems.
• Stronger  UM  interventions  are  structural    
• From  our  lab  UM  experience,  we  helped  
create  a  UM  product  for  insurance  
companies  and  Seattle  Children’s  
launched  PLUGS,  a  nonprofit  outreach  to  
hospitals  with  components  of  service,  
research,  and  teaching  
Value  =  Quality/Cost
Acknowledgements
• Seattle  Children’s  /  Univ  Washington  
– Jane  Dickerson
– Jessie  Conta
– Bonnie  Cole
– Darci  Sternen
– Shannon  Stasi
– John  Tait
– Patrick  Mathias
– Nitasha  Kumar
– Rhona  Jack
– Monica  Wellner  /  Lisa  Wick  and  the  Sendouts  and  CPA  
Teams
– Joe  Rutledge
– Mark  Del  Beccaro
– Geoff  Baird  
– Linda  Eckert
– Kevin  O’Brien
• Seattle  Children’s  Charitable  Foundation
• EviCore:  
• Lon  Castle
• Melissa  Bennet
• Denise  Needham
• Michael  Graf
• Individual  members  of  PLUGS
• Viewics
• Heidi  Wilbanks
• Tim  Kuruvilla  
Thank  you
Click  to  watch  on-­demand  webinar
(https://goo.gl/O1f5HG)

More Related Content

PDF
Patient Blood Management: Impact of Quality Data on Patient Outcomes
PDF
Tackling the U.S. Healthcare System’s Infectious Disease Management Problem
PDF
Revolutionizing Renal Care With Predictive Analytics for CKD
PDF
Advanced Laboratory Analytics — A Disruptive Solution for Health Systems
PDF
Advanced Lab Analytics for Patient Blood Management Programs
PDF
Methods for Observational Comparative Effectiveness Research on Healthcare De...
PPT
Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...
PDF
Using real-world evidence to investigate clinical research questions
Patient Blood Management: Impact of Quality Data on Patient Outcomes
Tackling the U.S. Healthcare System’s Infectious Disease Management Problem
Revolutionizing Renal Care With Predictive Analytics for CKD
Advanced Laboratory Analytics — A Disruptive Solution for Health Systems
Advanced Lab Analytics for Patient Blood Management Programs
Methods for Observational Comparative Effectiveness Research on Healthcare De...
Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...
Using real-world evidence to investigate clinical research questions

What's hot (20)

PPT
Greengold Presentation
PPTX
Do we need a new system to price oncology pharmaceuticals?
PDF
Applied use of CUSUMs in surveillance
PDF
Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
PPTX
How to Define Effective and Efficient Real World Trials
PDF
PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...
PDF
U of T Department of Family & Community Medicine PEARLS 2014
PPTX
Introduction to Healthcare Analytics
PPT
CATCH-IT Journal Club presentation Shamsa Jiwani
PPTX
Introduction of the NZ Health IT Plan enables better gout management
PPTX
Certified Nurse Leader (CNL) Capstone Project
PPTX
Evidence-Based Clinical Practice Guidelines for OBSTETRICS AND GYNECOLOGY
PPT
Enhancing the patient experience in a new purpose-build MDT meeting room with...
PDF
Engaging with data
PDF
CROs Driving Changes in Patient Recruitment
PDF
Evaluating new models of care: Improvement Analytics Unit
PDF
OTC Electronic Clinical Trial Recruitment
PDF
Healthcare analytics
PDF
Introduction to outcomes research
Greengold Presentation
Do we need a new system to price oncology pharmaceuticals?
Applied use of CUSUMs in surveillance
Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
How to Define Effective and Efficient Real World Trials
PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...
U of T Department of Family & Community Medicine PEARLS 2014
Introduction to Healthcare Analytics
CATCH-IT Journal Club presentation Shamsa Jiwani
Introduction of the NZ Health IT Plan enables better gout management
Certified Nurse Leader (CNL) Capstone Project
Evidence-Based Clinical Practice Guidelines for OBSTETRICS AND GYNECOLOGY
Enhancing the patient experience in a new purpose-build MDT meeting room with...
Engaging with data
CROs Driving Changes in Patient Recruitment
Evaluating new models of care: Improvement Analytics Unit
OTC Electronic Clinical Trial Recruitment
Healthcare analytics
Introduction to outcomes research
Ad

Similar to Best Practices for a Data-driven Approach to Test Utilization (20)

PDF
Strategies for Improving Laboratory Utilization
PPTX
Inappropriate use of laboratory resources.pptx
PDF
Test Utilization White Paper
PDF
Clinical laboratory test: Which, Why and What do results mean?.full
PDF
healthcare
PPT
Pre analytic and postanalytic test management
DOCX
Overview of the, clinicianb
PDF
(eBook PDF) Fischbach's A Manual of Laboratory and Diagnostic Tests 10th Edition
PDF
POL_INSIGHT_2013_A
PDF
Evidence Based Laboratory Medicine
PDF
Chapter Two- INTERPRETING CLINICAL LAB DATA- part-I (1).pdf
DOCX
When seeking to identify a patient’s health condition, advanced prac.docx
PPT
Laboratory Management With Constrains Iamm 2010
PDF
Lab Guide
DOCX
Assessment tools and Diagnostics test in Adults and children.docx
PPTX
4 Ways for Doctors to Avoid Inappropriate Testing
PPTX
Laboratory tests in psychiatry
PDF
LC_WH_BROCHURE-COMP-091310-LR
DOCX
Assessment tools and Diagnostics test in Adults and children.docx
DOCX
Assignment topic Rapid Influenza Testing in Children and Adult.docx
Strategies for Improving Laboratory Utilization
Inappropriate use of laboratory resources.pptx
Test Utilization White Paper
Clinical laboratory test: Which, Why and What do results mean?.full
healthcare
Pre analytic and postanalytic test management
Overview of the, clinicianb
(eBook PDF) Fischbach's A Manual of Laboratory and Diagnostic Tests 10th Edition
POL_INSIGHT_2013_A
Evidence Based Laboratory Medicine
Chapter Two- INTERPRETING CLINICAL LAB DATA- part-I (1).pdf
When seeking to identify a patient’s health condition, advanced prac.docx
Laboratory Management With Constrains Iamm 2010
Lab Guide
Assessment tools and Diagnostics test in Adults and children.docx
4 Ways for Doctors to Avoid Inappropriate Testing
Laboratory tests in psychiatry
LC_WH_BROCHURE-COMP-091310-LR
Assessment tools and Diagnostics test in Adults and children.docx
Assignment topic Rapid Influenza Testing in Children and Adult.docx
Ad

Recently uploaded (20)

PPTX
PE and Health 7 Quarter 3 Lesson 1 Day 3,4 and 5.pptx
PPT
Parental-Carer-mental-illness-and-Potential-impact-on-Dependant-Children.ppt
PDF
Megan Miller Colona Illinois - Passionate About CrossFit
PDF
Dr Masood Ahmed Expertise And Sucess Story
PPT
Recent advances in Diagnosis of Autoimmune Disorders
PPTX
Genaralised anxiety disorder presentation
PPTX
Pulmonary Circulation PPT final for easy
PDF
NUTRITION THROUGHOUT THE LIFE CYCLE CHILDHOOD -AGEING
PDF
Priorities Critical Care Nursing 7th Edition by Urden Stacy Lough Test Bank.pdf
PPTX
community services team project 2(4).pptx
PPTX
Immunity....(shweta).................pptx
PPTX
Medical aspects of impairment including all the domains mentioned in ICF
PPTX
First aid in common emergency conditions.pptx
PPTX
Rheumatic heart diseases with Type 2 Diabetes Mellitus
PDF
2E-Learning-Together...PICS-PCISF con.pdf
PPT
Adrenergic drugs (sympathomimetics ).ppt
PPTX
First Aid and Basic Life Support Training.pptx
PPTX
General Pharmacology by Nandini Ratne, Nagpur College of Pharmacy, Hingna Roa...
PPTX
Infection prevention and control for medical students
PPTX
3. Adherance Complianace.pptx pharmacy pci
PE and Health 7 Quarter 3 Lesson 1 Day 3,4 and 5.pptx
Parental-Carer-mental-illness-and-Potential-impact-on-Dependant-Children.ppt
Megan Miller Colona Illinois - Passionate About CrossFit
Dr Masood Ahmed Expertise And Sucess Story
Recent advances in Diagnosis of Autoimmune Disorders
Genaralised anxiety disorder presentation
Pulmonary Circulation PPT final for easy
NUTRITION THROUGHOUT THE LIFE CYCLE CHILDHOOD -AGEING
Priorities Critical Care Nursing 7th Edition by Urden Stacy Lough Test Bank.pdf
community services team project 2(4).pptx
Immunity....(shweta).................pptx
Medical aspects of impairment including all the domains mentioned in ICF
First aid in common emergency conditions.pptx
Rheumatic heart diseases with Type 2 Diabetes Mellitus
2E-Learning-Together...PICS-PCISF con.pdf
Adrenergic drugs (sympathomimetics ).ppt
First Aid and Basic Life Support Training.pptx
General Pharmacology by Nandini Ratne, Nagpur College of Pharmacy, Hingna Roa...
Infection prevention and control for medical students
3. Adherance Complianace.pptx pharmacy pci

Best Practices for a Data-driven Approach to Test Utilization

  • 1. Best  Practices  for  a  Data-­driven Approach  to  Test  Utilization MICHAEL  ASTION,  MD,  PHD AUG.  30,  2016
  • 2. Michael  Astion,  MD,  PhD • Medical  Director,  Department  of  Laboratories, Seattle  Children’s  Hospital • Clinical  Professor,  University  of  Washington, Department  of  Laboratory  Medicine Financial  disclosure  statement: • Univ.  Washington  Intellectual  Property  licensed  to – EviCore  Inc.,  (Guide  to  Lab  Utilization) – Medical  Training  Solutions • Dr.  Astion  is  employed  by  Seattle  Children’s  Hospital  and  is  here  representing  Seattle  Children’s.
  • 3. Agenda • Utilization  Management  (UM) – Background • Value  in  lab  testing.  Why  is  genetics  different? • Why  improve  utilization? • Trends  in  healthcare  affecting  UM – Data  from  insurance  claims – Interventions  to  improve  test  ordering • Seattle  Children’s  UM  plan/Pediatric  Laboratory  Utilization  Guidance   Service  (PLUGS) • Conclusions
  • 4. Why  improve  lab  utilization? • ¯ patient  costs • ¯ direct  lab  costs • ¯ societal  costs • ¯ false  +  results   especially  with  ¯ pretest  probability • ¯ worry • ¯ false  Dx,  associated  harms • ¯ unnecessary  work Value  =  Quality/Cost Warren JS. Lab test utilization program… Am J Clin Path. 2013;139:289-297.; Lewandrowski K. Managing utilization of new diagnostic tests. Clin Leadersh Manag Rev. 2003 Nov-Dec;17(6):318-24.; Kim  JY  et  al.  Utilization  management  in  a  large  urban  academic  medical  center.  AJCP.  2011;;135:108-­118.
  • 5. Root  causes  of  lab  overutilization     Care  providers Patients  Labs ­ testing Health  system google  …$$  incentive… fee  for  service malpractice  fear..   gene  patents... $  incentive… dissatisfaction… more  is  better... mktg  pressure… coding  system... patient  pressure… wellness  movement…
  • 6. Univ  Washington-­ EviCore  collaboration  to  study  lab  utilization  in   commercially-­insured  populations  in  the  USA  (2008  – present)   • Study  of  national,  regional  lab  insurance  claims  databases • Characteristics  of  largest  insurance  dbase  we  have  studied: – 1  year  of  data  (2009) – 3.5  million  covered  individuals  (members) – 8.2  million  doctor’s  visits  in  48  states – Total  spent  on  lab  was  $668  million.     – Lots  of  overutilization. • Example:  2.3%  of  members  had  ANA  test  (about  $  1  million  spent).  Prevalence  of   Lupus  in  population  is  0.2  – 1.5  per  1000 Eckert  LO,    Tait  JF,  Astion  ML,  et  al    2010.  Use  of  Molecular  Diagnostics  for  Lower  Genital  Tract  Complaints:    Comparison  of  Practice  Patterns  with  Published  Guidelines.  Am   College  of  Obstetrics  and  Gynecology  Annual  Meeting.;; Eckert  LO,  Astion  ML,  Tait  JF,    et  al.  2011.Use  of  molecular  diagnostics  in  women  without  genital  symptoms  presenting  for   Pap  smear:  How  common?  How  costly?  Infectious  Disease  Society  for  Obstetrics  and  Gynecology  (winner  of  outstanding  poster  award).;;  Bradley  SM,  Tait  J,  O’Brien  KD  et  al.   2011.  Use  of  novel  cardiovascular  risk  biomarkers  in  clinical  practice.  Annual  Meeting  for  Quality  of  Care  and  Outcomes  Research  in  Cardiovascular  Disease  and  Stroke.  
  • 7. Major  domains  of  overutilization Bundling  and  nonstandard  tests  are  drivers  in  all  domains • Wellness • CVD  risk • Pain • Women’s  health  (cervicitis,  vaginitis) • Nutrition  and  metals • Flow  cytometry • Allergy • Autoantibodies  (e.g.,  celiac  test  bundles) • Inpatients:  daily  labs • Genetic  testing,  especially  by  non-­geneticists Adults Peds Eckert  LO,    Tait  JF,  Astion  ML,  et  al    2010.    Am  College  of  Obstetrics  and  Gynecology  Annual  Meeting.;; Eckert  LO,  Astion  ML,  Tait  JF et  al.  2011.  Infectious  Disease  Society  for   Obstetrics  and  Gynecology;; Bradley  SM,  Tait  J,  O’Brien  KD,    et  al.  2011.  Annual  Mtg,  Quality  of  Care  and  Outcomes  Research  in  Cardiovascular  Disease  and  Stroke.  
  • 8. Overuse/  Misuse  of  Allergen-­specific  tests   Novel  biomarkers  are  overused  (4.4%  waste  of  $) Allergen specific  test #  visits   (Dates of  Service) $  spent  (%  of  total) IgE allergy  test 18553 $2,315,447  (95.7%) IgG-­IgG4 allergy  test 28 $71,420          (3.0%) ALC  antibody 48 $33,267            (1.4%) • Astion  M,  Tait  J,    et  al.  CareCore  collaboration,  unpublished  data • Used  our  largest  annual  database  of  3.5  million  covered  individuals • >500  clinical  labs  represented  in  the  >18,000  dates  of  service
  • 9. For  allergen-­specific  IgE  testing,  28  tests  per  doctor’s  visit  is  the  norm! 26  % 19  % 24  % 23  % 7  % 0 1000 2000 3000 4000 5000 6000 1  -­ 10  u 11  -­ 20  u 21  -­30  u   31  -­ 40  u >  40  u DOS Range  of  IgE  units • N  =  18,553  doctor’s  visits • Ave  units  of  allergen  specific  IgE  :  28 (SD:13,  Range:  12  – 71) • 54%  of  workups  are  associated  with  testing  >  21  allergens
  • 10. INTERVENTIONS  to  improve  utilization  require   backbone,  energy,  and  data “I’m  revitalized  and  ready  to   decrease  Vitamin  D  testing!”
  • 11. Seattle  Children’s  Hospital  approach  to  utilization   management  (UM)  is  typical  and  illustrative • Utilization  management  committee,  meets  weekly – 3  genetic  counselors – 4  -­ 6  doctoral  level  staff  including  pathologists,  medical  geneticists,  and  clinical   chemists – 2  lab  managers – Subcommittees  for  special  topics  (e.g.  exome  testing) • 1  GC,    1  doctor  on  call  for  UM  each  week. • All  UM  cases  recorded  in  database.  Dbase  allows  case  tracking,   consistency  in  case  resolution,  and  enables  research  and  QI • Emphasis  is  on  sendout  tests,  but  all  aspects  of  UM  are  covered. Dickerson  JA,  Cole  B,  Conta  JH,    et  al..  Improving  the  value  of  costly  genetic  reference  laboratory  testing  with  active  utilization  management.  Arch  Path  Lab  Med.  2014   Jan;;138(1):110-­3.
  • 12. Seattle  Children’s  Hospital:  What  test  requests  are   placed  under  active  management  with  review?   – Tests  >  $700 – Tests  ordered  for  multiple  genes – Requests  to  use  alternate  labs – Requests  for  banned  tests  or  labs – Request  for  test  labeled  in  lab  system  as  “Under  Management”    (e.g.,   reverse  T3) Dickerson  J,  et  al.    Ten  Ways  to  Improve  the  Quality  of  Send-­out  Testing.  Clin  Lab  News.  2012;;38(4):  12-­13.  www.aacc.org/publications/cln/2012/april/Pages/SendOutTesting.aspx#;;   Dickerson  JA,  Cole  B,  Conta  JH,    et  al..  Improving  the  value  of  costly  genetic  reference  laboratory  testing  with  active  utilization  management.  Arch  Path  Lab  Med.  2014   Jan;;138(1):110-­3.  
  • 13. Where  should  health  systems  focus  interventions?   It  is  most  realistic  to  focus  on  care  providers. Perverse Financial Incentives MD, RN, PA, other Patient Pressure Marketing Pressure Lab Test result Test order Astion  M.  Quackery  interventions:  The  hopelessness  and  the  hope.  Laboratory  Errors  and  Patient  Safety.2007.  4(1):  1  – 6.
  • 14. Common  weaker  interventions  to  improve  lab  utilization • Memos • Call  for  enhanced  vigilance • Training – Distribution  of  materials – Formal  continuing  education MEMO  10/07/10 To:  All  Providers  in  Clinic  X From:  Dr.  BigEgo,  Clinic  Chief Re:  Lab  test  utilization Stop  ordering  the  wrong  tests,   and  start  ordering  the  right  tests.   Please,  don’t  order  too  many   tests.    Be  more  careful.  You  all   don’t  know  what  you  are  doing.  
  • 15. • Posting  of  guidelines   on  the  requisition • Computerized   reminders  regarding   utilization  guidelines Utilization  Management  – Overview  of  Interventions Ÿ Utilization  report  cards  with   peer  review Ÿ Changes  to  manual   requisition Ÿ CPOE  templates Ÿ LIS  flagging  of  duplicate   orders Ÿ EMR  hard  and  soft  stops. Ÿ Privileging Ÿ Sendouts  formulary Ÿ Forbidding  tests Ÿ Requirement  for  higher   level  collaboration  or   approval  (e.g.   Pathologist  or  genetic   counselor  consultation) Gentle Strong Strength of Guidance Solomon DH et al. Techniques to improve…use of diagnostic tests. JAMA. 1998; 280:2020-2027.; Warren JS. Laboratory test utilization program: structure and impact in a large academic medical center. Am J Clin Pathol. 2013;139:289-297. Medium
  • 16. Influencing  physician  behavior IT  intervention Physician happiness Hard  stops Soft  stop Change  to  CPOE  templates,   Test  Definitions  and  Names Report  Cards  -­plain Report  Cards  with  +++   reinforcement One  useful  tactic  under  this  approach  is   nudging,  i.e.  steering  physicians  in  the   direction  that  we  know  is  usually  right,   while  still  giving  them  freedom  to  deviate   where  appropriate.  This  requires   engineering  the  information  environment  in   which  they  act,  such  that  usually  correct   actions  become  the  default,  and  deviation   requires  a  conscious  choice. —Dr.  Brian  Jackson,  ARUP/Univ  Utah Jackson  BR.  Nudging  our  way  to  more  efficient  care.  Clinical  Laboratory  News.  April   1,  2016.  www.aacc.org/publications/cln/articles/2016/april/nudging-­our-­way-­to-­more-­ efficient-­care-­how-­to-­win-­friends-­among-­doctors-­while-­influencing-­them
  • 17. Computerized  Reminders:  Less  is  More “I wouldn’t have ordered that! Do you know what you are doing? Y / N” “Would you like to discontinue standing order for electrolytes? Y / N” “Recommended screening test for thyroid disease is TSH.” Niazkhani et al. J Am Med Inform Assoc. 2009 16(4):539-49. Epub 2009 Apr 23.
  • 18. Changes  to  CPOE,  manual  requisitions,  and  test   definitions…   • …should  send  obsolete  tests  into   the  sunset  after  sending  a  phase   out  notice. • …for  manual  requisitions,  need  to   be  supported  by  a  policy  and   procedure  to  destroy old   requisitions • Make  unwanted  behavior  difficult   to  achieve;;  make  desired  behavior   easy Portion  of  a  requisition  for  genetics  tests  
  • 19. Effect  of  removing  ionized  Ca+2  from  requisition  and  replacing  it  with  reflexive   Ca+2  panel,  which  is  a  total  Ca+2,  and  ionized  Ca+2  if  total  Ca+2  <  8.0  mg/dL 0 1000 2000 3000 4000 5000 6000 Month Monthly  tally:  iCa+2 Hospital  1 Hospital  2 Baird  et  al.  Clin  Chem.  2009  Mar;;55:533-­40.  
  • 20. EMA  Monthly  Volumes Intervention  1:  email  with  phase  out  notice;;  other  communication Intervention  2:  Remove   from  orders 0  orders   after  Jan   2015 Monitor  Impact  of  an  intervention  to  eliminate  Endomysial  Antibody   (EMA  testing)  in  celiac  disease
  • 21. Example  of  a  typical  intervention: 1,25  Dihydroxyvitamin  D       Problem: • 1,25  Dihydroxyvit  D  is  common  send-­out  with  >  300  tests/yr • Retrospective  chart  review  found  68%  of    1,25  Vit  D  were  ordered  in  error  and  25  Vit  D  was   intended.   Intervention: • Email  describing  use  of  the  two  Vit  D  tests,  and  asking  if  provider  wants  to  change    to  25  Vit  D.     • Email  managed  by  front-­line  sendouts  staff. Dickerson  J,  Cole  B,  Jack  R,  Astion  M.    Another  laboratory  test  utilization  program:  our  approach  to  reducing  unnecessary  1,25  Vitamin  D  orders  with  a  simple  intervention.   Am  J  Clin  Pathol.  2013.  140(3):446-­7.
  • 22. 1,25  Vitamin  D  Intervention The  lab  received  a  request  for  1,25  dihydroxy  vitamin  D  on   your  patient. In  our  lab,  we  found  that  this  is    ordered  accidentally  68%  of   the  time. Utility  of  25-­ Vit  D  vs.  1,25  Vit  D   Two  options: 1. Cancel  and  add-­on  25-­OH  Vit  D 2. Proceed  with  original  order Dickerson  J,  Cole  B,  Jack  R,  Astion  M.    Another  laboratory  test  utilization  program:  our  approach  to  reducing  unnecessary  1,25  Vitamin  D  orders  with  a  simple  intervention.   Am  J  Clin  Pathol.  2013.  140(3):446-­7.
  • 23. 0 5 10 15 20 25 30 35 Number  of  Orders Cancelled Approved Intervention Privileging  added Effect  of  an  email  to  doctors  on  Vitamin  1,25  D  orders   (2012-­2013,  7  months) After  intervention:     • 58%  (n=134)  of  the  1,25   Vit  D    orders  were   changed  to  25  Vit  D. • 1,25  Vit  D  now  <10  /mo Dickerson  J,  Cole  B,  Jack  R,  Astion  M.    Another  laboratory  test  utilization  program:  our  approach  to  reducing   unnecessary  1,25  Vitamin  D  orders  with  a  simple  intervention.  Am  J  Clin  Pathol.  2013.  140(3):446-­7.
  • 24. Doctors  Love  the  1,25  Vitamin  D  Intervention I  am  not  making  these  up. “Thanks  so  much  for  your  help  (and  education). You  are  exactly  right—please   cancel  the  order  of  1,25  and  I’ll  add  on  for  25  hydroxy. ”   “Thank  you  so  much  for  the  email. You  are  correct  I  wanted  25-­hydroxy. I  will   cancel  and  reorder.”  
  • 25. Privileging “Dear  Send-­out  Team, I’ve  created  a  list  of  our  privileged  providers  who  do  not  need  to  be   contacted  regarding  ______  orders.  Simply,  send  these  tests  out.  ”
  • 26. SBAR:  Too  many  CBC-­DIFFs Situation:      High  proportion  of  CBCs  are  ordered  with  a  differential. Background: CBC-­Diffs  create  more  manual  work,  and  can  slow  down   the  laboratory  TAT  during  peak  times.     Assessment: CBCs  (without  differential)  are  sufficient  in  many  patient   populations. Recommendation:    Analyze  the  data,  identify  target  populations/divisions   to  pilot  interventions.
  • 27. Phase  1:  Provider  Feedback
  • 28. Phase  2:  Removed  CBC-­Diff  from  CICU  Ordersets 85%  of  CBCs  include  a  differential Cardiac  ICU  utilization  decreased  by  50% CBC CBC-­DIFF Thanks  to  Patrick  Mathias,  MD  PhD CICU NICU PICU Months  (Jan  2015  – June  2016) 100 90 80 70 60 50 40 30 20 10 Proportion  CBC-­DIFF  to  CBC  +  CBC-­DIFF
  • 29. Genetic  Counselors  as  a  form  of  enhanced  supervision In  this  study:  1  /  3  of     genetic  test  orders   were  in  error  and   correcting  the  order   improved  patient  care   and  saved  $  for   patients  and   hospitals. Miller C.  Clin  Lab  News. 2012:  38(1).  www.aacc.org/publications/cln/2012/january
  • 30. Email  template  to  physicians  who  are  not Medical  Geneticists   but  who  are  ordering  expensive  genetic  tests   Lab  received  expensive,  unusual  request  on  your  patient: You  have  3  options: 1.  Involve  genetics  or  lab  GC 2.  Hold  for  pre-­authorization   3.  Proceed  after  telling  $cost  to  patient Info  on  completing  insurance  pre-­auth
  • 31. A  day  in  the  UM  life  at  SCH…  32%  of  genetic  test   requests  are  canceled  or  decreased Request   received  by   SO  team E-­mail  to   Lab  GC/ SO  Consultant Case  review   &   Adjudication Approved Additional   information   needed Discussion   with  ordering   provider Modified Cancelled Outcome 68% 10%22% Dickerson  JA,  Cole  B,  Conta  JH,    et  al..  Improving  the  value  of  costly  genetic  reference  laboratory  testing  with  active  utilization  management.  Arch  Path  Lab  Med.  2014  Jan;;138(1):110-­ 3.  
  • 32. $6,033,371* Total  genetic  requests   $980,953 savings   $5,052,418 Actual 32%  order   modification ~$340  saved per  request *Data  collected  Sept  2011  – Feb  2016 N=2908  genetic  cases Seattle  Children’s  Hospital Financial  Implications  of  UM
  • 33. SCH  UM  Dashboard Turn-­around  Time Requests  Over  Time Cost  – Cost  Savings Request  Details
  • 34. PLUGS:  nationalizing  our  experience Mission/Vision • Needs  expenses  while   increasing  the  value  of   testing  to  patients. • Be  the  #1  provider  of   services  that  promote   pediatric  test  utilization   management  (UM)   programs  in  hospitals  and   health  systems. Goal • Help  hospitals  implement   /  strengthen  their  own  UM   programs Outcomes • Decrease  ordering  errors   • Decrease  send-­out  bill  for   genetic  tests  by  20-­40% • Decrease  send-­out  bill  for   non-­genetic  tests  by  10% • Decrease  patient   complaints  by  reducing   out  of  pocket  expenses   and  unnecessary  testing. Pediatric  Laboratory  Utilization  Guidance  Services
  • 35. THANK  YOU  TO  OUR  SPONSORS  &  PARTNERS: 56  INSTITUTIONS,  AND  COUNTING…     Health  Partners:  Regions  Hospital  &  Park  Nicolette  Hospitals   Intermountain/Primary  Children’s  Hospital Johns  Hopkins  Hospital   Lancaster  General  Hospital Le  Bonheur  Children’s  Hospital   Lurie  Children’s  Hospital  Chicago Mercy  Children’s  Hospital  – St.  Louis Meriter-­ Unity  Point  Health Medical  Neurogenetics  (MNG)  Laboratories MultiCare  Tacoma  General   Nationwide  Children's  Hospital   Nemours/Alfred  I.  duPont  Hospital  for  Children Nationwide  Children’s  Hospital Norton  Healthcare Oregon  Health  Sciences  University Phoenix  Children’s  Hospital PWN  Health Quest  Diagnostics Salem  Health Stanford  Health  Care St.  Louis  Children’s  Hospital Tricore  Reference  Lab University  of  Florida-­ Shands   University  of  Michigan University  of  Washington Wake  Forest  Baptist  Health York  Hospital  (WellSpan  Health  System) Akron  Children's  Hospital Arkansas  Children’s  Hospital Baylor  Genetics Bronson  Methodist  Hospital Blood  Center  of  Wisconsin Boston  Children’s  Hospital Cardinal  Glennon,  SSMH CentraCare  Health Children’s  of  Alabama   Children’s  Healthcare  of  Atlanta Children's  Hospital  &  Clinics  of  MN Children's  Hospital  of  Colorado   Children’s  Hospital  of  Los  Angeles Children’s  Hospital  of  Philadelphia Children’s  Hospital  of  Pittsburgh  of  UPMC Children’s  Hospital  of  Wisconsin Children’s  Mercy  Hospital Children’s  National  Medical  Center Cincinnati    Children’s  Hospital Cleveland  Clinic Connecticut  Children’s  Hospital Dayton  Children’s  Hospital     Dell  Children’s   Fairview  Health  Services GeneDx
  • 36. PLUGS    provides… UM  Tools • Needs  assessment  and  1  year   plan • Policies,  procedures  &   communication  templates  that   help  providers  reduce   unnecessary  testing  &  correct   test  orders • Database  for  collecting,   tracking  &  analyzing  UM   cases • Tools  to  assess  risk  of  errors   in  send-­outs • Provider  satisfaction  survey Communication • Office  hours/call  center • Weekly  newsletter • Member  teleconferences  with   presentations  by  SCH  team  &   members • Website:   www.seattlechildrens.org • Discussion  forum Education • Tips  &  tricks  from  PLUGS   experts • UM  learning  modules • UM  webinars • Case  of  the  Week • Extensive  materials  on  how  to   get  a  UM  program  started  in  a   lab  or  hospital • PLUGS  Summit
  • 37. PLUGS  Summit  (June  2017) • 10  hours,  CME/CEU • Sharing  best  practices • Debates  /  Roundtables • Posters • Networking  (nice  party) • Largest  lab  utilization  management   gathering – >175  participants – Labs – IT  companies – Insurance  companies
  • 38. Conclusions  and  Thanks! • Lab  test  utilization  management     improves  value  to  patients. • It  is  here  to  stay. • Over  the  next  10  years,  most  testing  will   be  actively  managed  by  insurers  and   hospital  systems. • Stronger  UM  interventions  are  structural     • From  our  lab  UM  experience,  we  helped   create  a  UM  product  for  insurance   companies  and  Seattle  Children’s   launched  PLUGS,  a  nonprofit  outreach  to   hospitals  with  components  of  service,   research,  and  teaching   Value  =  Quality/Cost
  • 39. Acknowledgements • Seattle  Children’s  /  Univ  Washington   – Jane  Dickerson – Jessie  Conta – Bonnie  Cole – Darci  Sternen – Shannon  Stasi – John  Tait – Patrick  Mathias – Nitasha  Kumar – Rhona  Jack – Monica  Wellner  /  Lisa  Wick  and  the  Sendouts  and  CPA   Teams – Joe  Rutledge – Mark  Del  Beccaro – Geoff  Baird   – Linda  Eckert – Kevin  O’Brien • Seattle  Children’s  Charitable  Foundation • EviCore:   • Lon  Castle • Melissa  Bennet • Denise  Needham • Michael  Graf • Individual  members  of  PLUGS • Viewics • Heidi  Wilbanks • Tim  Kuruvilla  
  • 40. Thank  you Click  to  watch  on-­demand  webinar (https://goo.gl/O1f5HG)

Editor's Notes

  • #16: 15
  • #25: Privileging
  • #30: A recent study at ARUP, a major reference laboratory did a study where they had all genetics tests vetted by a genetic counselor. They concluded that 1/3 of genetic tests were ordered incorrectly which had major cost implications. By correcting the orders they simultaneously improved patient care and saved hospitals and ultimately patients half a million dollars per year.
  • #32: Discuss process (tests flagged as “UM” or manual review of MISC orders), e-mail template, review of clinic notes & insurance preauth, follow-up information gathered by phone or e-mail, case is approved, modified (give example), or provider decides to cancel. Review/adjudication same day or next business day. All info is capture in database to facilitate steps of the UM process (e.g. sequential testing), monitor metrics (e.g. cost savings) and facilitate weekly case review discussion (e.g. ensure similar case adjudication each time).
  • #33: In addition to correct orders and improving the quality of testing. The savings from this program allow us to bolster other lab operations (e.g. phlebotomists, etc) , our intervention has a significant financial impact for the institution and families directly – we know that we are improving satisfaction and preventing surprise bills in the mail.
  • #34: Overview of dashboard, where it’s posted at SCH, hospital goals/strategic plan
  • #36: Subscription bases service –
  • #40: I moved this slide to the end because it seemed to make more sense here. If you need to move it back to the beginning, that’s fine.